CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies

3.2.1.1. Competitive intelligence and strategies of companies

3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing elderly population
3.4.1.2. Increasing incidences of arthritis and osteoporosis
3.4.1.3. Technological advancements in the VCF devices
3.4.1.4. Shift towards minimal invasive VCF procedures

3.4.2. Restraints

3.4.2.1. Stringent regulatory approval procedure

3.4.3. Opportunities

3.4.3.1. Emerging markets to drive the demand for VCF devices
3.4.3.2. Popularization of percutaneous vertebral augmentation (PVA) treatment

3.4.4. Impact analysis

3.5. PORTERS FIVE FORCES ANALYSIS

3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry

3.6. GOVERNMENT REGULATIONS

CHAPTER 4 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast
4.1.4. Global VCF Device Implantations, By Type
4.1.5. Balloon kyphoplasty devices

4.1.5.1. Market size and forecast

4.1.6. Vertebroplasty devices

4.1.6.1. Market size and forecast

CHAPTER 5 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. OPEN SURGERY

5.2.1. Market size and forecast

5.3. MINIMALLY INVASIVE SURGERY

5.3.1. Market size and forecast

CHAPTER 6 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. France market size and forecast
6.3.5. Germany market size and forecast
6.3.6. UK market size and forecast
6.3.7. Spain market size and forecast
6.3.8. Italy market size and forecast
6.3.9. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. India market size and forecast
6.4.5. China market size and forecast
6.4.6. Japan market size and forecast
6.4.7. South Korea market size and forecast
6.4.8. Australia market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. ALPHATEC HOLDINGS, INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating product categories
7.1.4. Business Performance
7.1.5. Key strategic moves and developments

7.2. OSSEON LLC

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Key strategic moves and developments

7.3. ORTHOVITA, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Key strategic moves and developments

7.4. JOHNSON & JOHNSON

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments

7.5. GLOBUS MEDICAL, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Key strategy share

7.6. MEDTRONIC PLC

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Key strategy share

7.7. BENVENUE MEDICAL

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Key strategic moves and developments
7.7.4. Key strategy share

7.8. VEXIM SA

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Key strategic moves and developments
7.8.4. Key strategy share

7.9. STRYKER CORPORATION

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments

7.10. ZIMMER BIOMET HOLDINGS, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Key strategy share